Adcock Ingram Holdings | AIP - Pre Tax Profit


Adcock Ingram Holdings reported ZAR25.97M in Pre-Tax Profit for its fiscal semester ending in June of 2024.



Pre Tax Profit Change Date
Akebia Therapeutics USD -11.24M 12.39M Dec/2025
Alaunos Therapeutics USD -7.84M 633K Dec/2023
Aspen Pharmacare ZAR 1.4B 51M Jun/2024
Avita Medical AUD -11.64M 12.13M Dec/2025
Dianthus Therapeutics USD -64.43M 27.67M Dec/2025
Ionis Pharmaceuticals USD -228M 99M Dec/2025
IQVIA Holdings USD 6.16B 5.84B Sep/2025
Moderna USD -187M 631M Sep/2025
Organon & Co USD 243M 14M Sep/2025
Revvity USD 55.68M 115.97M Sep/2025
Tectonic Therapeutic USD -18.97M 63K Dec/2025
Viatris USD -7.9M 209.2M Sep/2025
Xeris Pharmaceuticals USD 11.08M 10.46M Dec/2025